China Health Group (00673) announced that on October 12, 2023, the buyer (Longheng Investment Co., Ltd., a wholly-owned subsidiary of the company) intends to acquire all of the shares in the target company (Jinmei Development Co., Ltd.) from the seller (Yongcheng Venture Capital Co., Ltd.) at a cost of HK$146 million, which will be paid by the company issuing acceptance notes to the seller.
The announcement stated that the completed matters were confirmed on November 16, 2023.